Biotech · Private company
PeproMene Bio, Inc.
Track this companyFree. Adds PeproMene Bio, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- BAFFR-CAR T cellsPhase 1 · Relapsed or Refractory B-cell Acute Lymphoblastic LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- BAFFR-CAR T cellsPhase 1 · Relapsed or Refractory B-cell Non-Hodgkin's LymphomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHLPHASE1 · RECRUITING · started Jun 13, 2022ClinicalTrials.gov NCT05370430 · fetched Nov 12, 2026
- BAFFR Targeting CAR-T Cells for the Treatment of Relapsed or Refractory B-cell ALLPHASE1 · ACTIVE_NOT_RECRUITING · started May 18, 2021ClinicalTrials.gov NCT04690595 · fetched Nov 12, 2026